For this purpose, we evaluated the mRNA expression level of BTLA gene in the subset of T cells (CD3-positive cells) and B cells (CD19-positive cells) separated from the blood samples of CLL pts. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.